Your browser doesn't support javascript.
loading
Analysis of Semiology, Lesion Topography and Treatment Outcomes: A Prospective Study on Post Thalamic Stroke Holmes Tremor.
Datta, Amlan Kusum; Mukherjee, Adreesh; Malakar, Sudeshna; Biswas, Atanu.
Afiliação
  • Datta AK; Institute of Post Graduate Medical Education & Research and Bangur Institute of Neurosciences, West Bengal, India.
  • Mukherjee A; Institute of Post Graduate Medical Education & Research and Bangur Institute of Neurosciences, West Bengal, India.
  • Malakar S; Department of Radiology, Apollo Multispeciality Hospitals, West Bengal, India.
  • Biswas A; Institute of Post Graduate Medical Education & Research and Bangur Institute of Neurosciences, West Bengal, India.
J Mov Disord ; 17(1): 71-81, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37859346
ABSTRACT

OBJECTIVE:

Holmes tremor (HT) comprises rest, postural and intention tremor subtypes, usually involving both proximal and distal musculature. Perturbations of nigro-striatal pathways might be fundamental in the pathogenesis of HT along with cerebello-thalamic connections.

METHODS:

Nine patients with an HT phenotype secondary to thalamic stroke were included. Epidemiological and clinical records were obtained. Structural and functional brain imaging were performed with magnetic resonance imaging (MRI) or computed tomography (CT) and positron emission tomography (PET), respectively. Levodopa was administered in sequentially increasing dosage, with various other drugs in case of inadequate response. Longitudinal follow-up was performed for at least three months. The essential tremor rating assessment scale (TETRAS) was used for assessment.

RESULTS:

The mean latency from stroke to tremor onset was 50.4 ± 30.60 days (range 21-90 days). Dystonia was the most frequently associated hyperkinetic movement (88.8%). Tremor was bilateral in 22.2% of participants. Clinical response was judged based on a reduction in the TETRAS score by a prefixed value (≥ 30%), pertaining to which 55.5% (n = 5) of subjects were classified as responders and the rest as non-responders. The responders showed improvement with significantly lower doses of levodopa than the remaining nonresponders (240 ± 54.7 mg vs. 400 ± 40.8 mg; p = 0.012).

CONCLUSION:

Although levodopa is useful in HT, augmenting the dosage of levodopa beyond a certain point might not benefit patients clinically. Topography of vascular lesions within the thalamus might additionally influence the phenomenology of HT.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article